Mixed-lineage leukemia translocated to 11 (MLLT11), also called the ALL1-fused gene from the chromosome 1q (AF1Q) gene, has been found to be overexpressed in ovarian cancer and to be associated with a poor patient outcome [13]. This evidence concerns the gene MLLT11 and ovarian cancer.